序号 |
标题 |
次数 |
作者 |
发布时间 |
316 |
Cbz-NH-PEG8-CH2COOH |
4 |
h |
2024-12-20 |
317 |
CAS: 2055024-60-5,NH2-PEG6-Val-Cit-PAB-OH |
2 |
WYQ |
2024-12-20 |
318 |
苄基-PEG4-乙酸叔丁酯,cas:1443467-88-6,Benzyl-PEG4-CH2CO2tBu |
2 |
wyh |
2024-12-20 |
319 |
Boc-NH-PEG6-CH2COOH |
6 |
h |
2024-12-20 |
320 |
NEs介导的紫杉醇脂质体药物递送系统(NE-LP-PTX),定制服务 |
4 |
axc |
2024-12-20 |
321 |
perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,抗体药物偶联物(ADC) |
3 |
kx |
2024-12-20 |
322 |
CAS: 2055024-61-6,NH2-PEG4-Val-Cit-PAB-OH |
5 |
WYQ |
2024-12-20 |
323 |
Azido-PEG7-CH2COOH |
3 |
h |
2024-12-20 |
324 |
mb-vc-MGBA-ADC连接子 |
4 |
zyl |
2024-12-20 |
325 |
Azido-PEG2-CH2COOH |
4 |
h |
2024-12-20 |
326 |
cas:1263044-88-7,2,5-dioxopyrrolidin-1-yl 1-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate |
3 |
kx |
2024-12-20 |
327 |
Br-PEG6-CH2COOtBu |
6 |
h |
2024-12-20 |
328 |
白蛋白结合肽修饰的地塞米松脂质体,ABD-Lip/Dex,定制服务 |
2 |
axc |
2024-12-20 |
329 |
Maleimido-mono-amide-DOTA cas:1006711-90-5 |
3 |
zyl |
2024-12-20 |
330 |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate,ADC定制 |
3 |
kx |
2024-12-20 |
331 |
Tos-PEG3-CH2COOtBu |
4 |
h |
2024-12-20 |
332 |
溶菌酶修饰的百里香精油脂质体,定制服务 |
7 |
axc |
2024-12-20 |
333 |
HO-PEG7-CH2COOH |
5 |
h |
2024-12-20 |
334 |
Mc-vc-PABC-SP 141 -ADC连接子 |
3 |
zyl |
2024-12-20 |
335 |
CAS: 2055024-53-6,Boc-PEG6-Val-Cit-PAB-OH |
6 |
WYQ |
2024-12-20 |
336 |
cas:1252257-56-9,2,5-dioxopyrrolidin-1-yl 3-oxo-1-(pyridin-2-yldisulfanyl)-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate |
2 |
kx |
2024-12-20 |
337 |
Amino-PEG12-CH2COOH |
3 |
h |
2024-12-20 |
338 |
CAS: 2055024-54-7,Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
2 |
WYQ |
2024-12-20 |
339 |
HO-PEG12-CH2COOH |
4 |
h |
2024-12-20 |
340 |
cas:663599-07-3,1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
4 |
kx |
2024-12-20 |
341 |
E-选择素结合肽修饰并加载四嗪的膜融合脂质体,EBP-Tz-FLs,定制服务 |
2 |
axc |
2024-12-20 |
342 |
Amino-PEG3-CH2COOH |
3 |
h |
2024-12-20 |
343 |
CAS: 2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH |
8 |
WYQ |
2024-12-20 |
344 |
Tos-PEG4-CH2COOH |
2 |
h |
2024-12-20 |
345 |
cas:663598-85-4,N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate, ADC试剂 |
3 |
kx |
2024-12-20 |
346 |
负载姜黄素的胆碱修饰的脂质体,NP1/Cur,定制服务 |
2 |
axc |
2024-12-20 |
347 |
Boc-NH-PEG4-CH2COOH |
2 |
h |
2024-12-20 |
348 |
CAS: 1951424-92-2,Fmoc-Ala-Ala-Asn(Trt)-OH |
4 |
WYQ |
2024-12-20 |
349 |
CAS:1618096-56-2 Mc-Dexamethasone 抗体-药物偶联物(ADC) |
8 |
zyl |
2024-12-20 |
350 |
CAS: 1639939-40-4,MC-Val-Ala-PAB-PNP |
4 |
WYQ |
2024-12-20 |
351 |
Fmoc-NH-PEG4-CH2COOH |
4 |
h |
2024-12-20 |
352 |
perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate,ADC定制 |
2 |
kx |
2024-12-20 |
353 |
CAS: 1870916-87-2,MC-Val-Ala-PAB,6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-N-((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁-2-基)己酰胺 |
5 |
WYQ |
2024-12-20 |
354 |
Amino-PEG4-CH2COOH |
5 |
h |
2024-12-20 |
355 |
CAS号1473403-87-0 MC-SN38 抗体-药物偶联物(ADC) |
9 |
zyl |
2024-12-20 |
356 |
Alkyne-Val-Cit-PAB-PNP(CAS号:2748039-77-0) |
3 |
WYQ |
2024-12-20 |
357 |
Fmoc-NH-PEG4-CH2CH2COOH |
6 |
h |
2024-12-20 |
358 |
cas:1007215-94-2,tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate |
4 |
kx |
2024-12-20 |
359 |
HS-PEG5-CH2CH2NH2 hydrochloride |
7 |
h |
2024-12-20 |
360 |
Thiol-PEG5-amine |
6 |
h |
2024-12-20 |